Literature DB >> 27235017

Neuropeptide S differently modulates alcohol-related behaviors in alcohol-preferring and non-preferring rats.

Nazzareno Cannella1, Marsida Kallupi1, Hong Wu Li1, Serena Stopponi1, Carlo Cifani1, Roberto Ciccocioppo1, Massimo Ubaldi2.   

Abstract

RATIONALE: Neuropeptide S (NPS) displays unique pharmacological properties and induces both anxiolytic and pro-stress/arousal activities. Previous studies performed using Wistar rats demonstrated that NPS facilitated alcohol and cocaine seeking but did not affect alcohol or cocaine consumption.
OBJECTIVES: Here, we investigated the effects of NPS in Marchigian Sardinian alcohol-preferring (msP) rats, a rat strain characterized by excessive alcohol consumption comorbid with heightened anxiety and depressive-like phenotypes. Specifically, we evaluated the effect of NPS on operant alcohol self-administration by msP rats compared to Wistar rats. The effect of NPS on cue-induced reinstatement of alcohol seeking in msP rats was also evaluated. Finally, using the open field test (OFT) and the elevated plus maze (EPM), we evaluated the effects of NPS on locomotor activity and anxiety.
RESULTS: NPS reduced alcohol self-administration but did not affect cue-induced reinstatement in the msP rat. In addition, NPS induced reinstatement of extinguished alcohol seeking in Wistar rats without affecting alcohol intake. In the EPM task, NPS, in accordance with its anxiolytic activity, increased the time spent in the open arm of the arena by msP rats, although this effect was not observed in Wistar rats.
CONCLUSIONS: These data suggest that the effect of NPS is strongly influenced by the genetic background of the animal. In Wistar rats, NPS acts as a pro-arousal agent to promote the reinstatement of alcohol seeking. However, when alcohol drinking is motivated by or associated with a state of pathological anxiety, NPS attenuates alcohol consumption and seeking due to its anxiolytic activity.

Entities:  

Keywords:  Abuse; Addiction; CNS; Ethanol; NPSR; Relapse

Mesh:

Substances:

Year:  2016        PMID: 27235017      PMCID: PMC4935615          DOI: 10.1007/s00213-016-4333-7

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  36 in total

1.  Polymorphism in the corticotropin-releasing factor receptor 1 (CRF1-R) gene plays a role in shaping the high anxious phenotype of Marchigian Sardinian alcohol-preferring (msP) rats.

Authors:  Andrea Cippitelli; Lydia O Ayanwuyi; Estelle Barbier; Esi Domi; Jose M Lerma-Cabrera; Francisca Carvajal; Giulia Scuppa; Hongwu Li; Massimo Ubaldi; Markus Heilig; Marisa Roberto; Roberto Ciccocioppo
Journal:  Psychopharmacology (Berl)       Date:  2014-09-27       Impact factor: 4.530

2.  Hypothalamic neuropeptide S receptor blockade decreases discriminative cue-induced reinstatement of cocaine seeking in the rat.

Authors:  Marsida Kallupi; Giordano de Guglielmo; Nazzareno Cannella; Hong Wu Li; Girolamo Caló; Remo Guerrini; Massimo Ubaldi; John J Renger; Victor N Uebele; Roberto Ciccocioppo
Journal:  Psychopharmacology (Berl)       Date:  2012-11-13       Impact factor: 4.530

Review 3.  Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism.

Authors:  Roberto Ciccocioppo; Daina Economidou; Andrea Cippitelli; Marino Cucculelli; Massimo Ubaldi; Laura Soverchia; Anbarasu Lourdusamy; Maurizio Massi
Journal:  Addict Biol       Date:  2006-09       Impact factor: 4.280

4.  Immunohistochemical localization of the neuropeptide S receptor in the rat central nervous system.

Authors:  S K Leonard; R H Ring
Journal:  Neuroscience       Date:  2010-10-13       Impact factor: 3.590

5.  Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain.

Authors:  Yan-Ling Xu; Christine M Gall; Valerie R Jackson; Olivier Civelli; Rainer K Reinscheid
Journal:  J Comp Neurol       Date:  2007-01-01       Impact factor: 3.215

Review 6.  Stress-related neuropeptides and addictive behaviors: beyond the usual suspects.

Authors:  Jesse R Schank; Andrey E Ryabinin; William J Giardino; Roberto Ciccocioppo; Markus Heilig
Journal:  Neuron       Date:  2012-10-04       Impact factor: 17.173

7.  Morphine dependence is associated with changes in neuropeptide S receptor expression and function in rat brain.

Authors:  Pasha Ghazal; Roberto Ciccocioppo; Massimo Ubaldi
Journal:  Peptides       Date:  2013-05-16       Impact factor: 3.750

8.  Persistent increase of alcohol-seeking evoked by neuropeptide S: an effect mediated by the hypothalamic hypocretin system.

Authors:  Nazzareno Cannella; Daina Economidou; Marsida Kallupi; Serena Stopponi; Markus Heilig; Maurizio Massi; Roberto Ciccocioppo
Journal:  Neuropsychopharmacology       Date:  2009-03-25       Impact factor: 7.853

9.  Neuropeptide S is a stimulatory anxiolytic agent: a behavioural study in mice.

Authors:  A Rizzi; R Vergura; G Marzola; C Ruzza; R Guerrini; S Salvadori; D Regoli; G Calo
Journal:  Br J Pharmacol       Date:  2008-03-31       Impact factor: 8.739

Review 10.  Neuropeptide S: a transmitter system in the brain regulating fear and anxiety.

Authors:  Hans-Christian Pape; Kay Jüngling; Thomas Seidenbecher; Jörg Lesting; Rainer K Reinscheid
Journal:  Neuropharmacology       Date:  2009-06-10       Impact factor: 5.250

View more
  9 in total

Review 1.  Building better strategies to develop new medications in Alcohol Use Disorder: Learning from past success and failure to shape a brighter future.

Authors:  Nazzareno Cannella; Massimo Ubaldi; Alessio Masi; Massimo Bramucci; Marisa Roberto; Angelo Bifone; Roberto Ciccocioppo
Journal:  Neurosci Biobehav Rev       Date:  2019-05-18       Impact factor: 8.989

Review 2.  Rat animal models for screening medications to treat alcohol use disorders.

Authors:  Richard L Bell; Sheketha R Hauser; Tiebing Liang; Youssef Sari; Antoniette Maldonado-Devincci; Zachary A Rodd
Journal:  Neuropharmacology       Date:  2017-02-16       Impact factor: 5.250

3.  phMRI, neurochemical and behavioral responses to psychostimulants distinguishing genetically selected alcohol-preferring from genetically heterogenous rats.

Authors:  A Bifone; A Gozzi; A Cippitelli; A Matzeu; E Domi; H Li; G Scuppa; N Cannella; M Ubaldi; F Weiss; R Ciccocioppo
Journal:  Addict Biol       Date:  2018-10-17       Impact factor: 4.280

Review 4.  Pharmacology, Physiology and Genetics of the Neuropeptide S System.

Authors:  Rainer K Reinscheid; Chiara Ruzza
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-23

Review 5.  Genetically selected alcohol-preferring msP rats to study alcohol use disorder: Anything lost in translation?

Authors:  Anna Maria Borruto; Serena Stopponi; Hongwu Li; Friedbert Weiss; Marisa Roberto; Roberto Ciccocioppo
Journal:  Neuropharmacology       Date:  2021-01-18       Impact factor: 5.273

6.  Inactivation of the Prelimbic Cortex Impairs the Context-Induced Reinstatement of Ethanol Seeking.

Authors:  Paola Palombo; Rodrigo M Leao; Paula C Bianchi; Paulo E C de Oliveira; Cleopatra da Silva Planeta; Fábio C Cruz
Journal:  Front Pharmacol       Date:  2017-10-17       Impact factor: 5.810

Review 7.  The Neural Network of Neuropeptide S (NPS): Implications in Food Intake and Gastrointestinal Functions.

Authors:  Luca Botticelli; Emanuela Micioni Di Bonaventura; Massimo Ubaldi; Roberto Ciccocioppo; Carlo Cifani; Maria Vittoria Micioni Di Bonaventura
Journal:  Pharmaceuticals (Basel)       Date:  2021-03-26

Review 8.  A Role for Neuropeptide S in Alcohol and Cocaine Seeking.

Authors:  Nazzareno Cannella; Anna Maria Borruto; Michele Petrella; Maria Vittoria Micioni Di Bonaventura; Laura Soverchia; Carlo Cifani; Sara De Carlo; Esi Domi; Massimo Ubaldi
Journal:  Pharmaceuticals (Basel)       Date:  2022-06-27

Review 9.  Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review.

Authors:  Pascal Valentin Fischler; Michael Soyka; Erich Seifritz; Jochen Mutschler
Journal:  Front Pharmacol       Date:  2022-10-03       Impact factor: 5.988

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.